Methods for predicting response of triple-negative breast cancer to therapy

Details for Australian Patent Application No. 2011205343 (hide)

Owner Nestec S.A.

Inventors Liu, Xinjun; Kim, Phillip; Kirkland, Richard; Lee, Tani; Ybarrondo, Belen; Singh, Sharat

Agent Shelston IP

Pub. Number AU-A-2011205343

PCT Pub. Number WO2011/088149

Priority 61/328,602 27.04.10 US; 61/325,624 19.04.10 US; 61/294,433 12.01.10 US; 61/351,838 04.06.10 US

Filing date 12 January 2011

Wipo publication date 21 July 2011

International Classifications

G01N 33/574 Investigating or analysing materials by specific methods not covered by groups - for cancer

A61P 35/00 Antineoplastic agents

C12Q 1/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/15 Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

Event Publications

2 August 2012 PCT application entered the National Phase

  PCT publication WO2011/088149 Priority application(s): WO2011/088149

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011205349-Materials and methods for producing cell-surface directed and associated non-naturally occurring bioinorganic membranes and uses thereof

2011205330-Wind turbine generator and motor